These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10762457)

  • 21. Chlamydia in coronary plaques--hidden culprit or harmless hobo?
    Capron L
    Nat Med; 1996 Aug; 2(8):856-7. PubMed ID: 8705849
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of Chlamydia pneumoniae in cardiovascular disease.
    Gaydos CA; Quinn TC
    Adv Intern Med; 2000; 45():139-73. PubMed ID: 10635048
    [No Abstract]   [Full Text] [Related]  

  • 23. Does Chlamydia pneumoniae have a role in atherosclerosis?
    Byers J; Robertson R
    JAAPA; 2002 May; 15(5):50-2, 55-7. PubMed ID: 12063818
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chlamydia pneumoniae infection and atherosclerosis].
    Sumarokov AB; Liakishev AA
    Klin Med (Mosk); 1999; 77(7):4-10. PubMed ID: 10483155
    [No Abstract]   [Full Text] [Related]  

  • 25. Current knowledge of Chlamydia pneumoniae and atherosclerosis.
    Hammerschlag MR
    Eur J Clin Microbiol Infect Dis; 1998 May; 17(5):305-8. PubMed ID: 9721957
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic infection in the aetiology of atherosclerosis--focus on Chlamydia pneumoniae.
    Gupta S
    Atherosclerosis; 1999 Mar; 143(1):1-6. PubMed ID: 10208475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery.
    Mosorin M; Surcel HM; Laurila A; Lehtinen M; Karttunen R; Juvonen J; Paavonen J; Morrison RP; Saikku P; Juvonen T
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1061-7. PubMed ID: 10764674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration.
    Kalayoglu MV; Galvan C; Mahdi OS; Byrne GI; Mansour S
    Arch Ophthalmol; 2003 Apr; 121(4):478-82. PubMed ID: 12695244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence?
    Camm AJ; Fox KM
    Eur Heart J; 2000 Jul; 21(13):1046-51. PubMed ID: 10843822
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chlamydia pneumoniae and atherosclerosis].
    Fortini A; Corti G; Cappelletti C
    Ann Ital Med Int; 1999; 14(4):253-63. PubMed ID: 10638018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlamydia pneumoniae and atherosclerosis--an update.
    Saikku P
    Scand J Infect Dis Suppl; 1997; 104():53-6. PubMed ID: 9259083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherosclerosis and infection due to Chlamydia pneumoniae or cytomegalovirus: weighing the evidence.
    High KP
    Clin Infect Dis; 1999 Apr; 28(4):746-9. PubMed ID: 10825031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chlamydia pneumoniae and arteriosclerosis].
    Lapetra J; Santos JM; Gil-Peralta A; Mayoral E; González-Marcos JR
    Rev Neurol; 1999 Feb 1-15; 28(3):251-5. PubMed ID: 10714290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis.
    Choi EY; Kim D; Hong BK; Kwon HM; Song YG; Byun KH; Park HY; Whang KC; Kim HS
    Exp Mol Med; 2002 Dec; 34(6):391-400. PubMed ID: 12526080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlamydia pneumoniae antibodies associated with altered serum lipid profile.
    Laurila AL; Bloigu A; Näyhä S; Hassi J; Leinonen M; Saikku P
    Int J Circumpolar Health; 1998; 57 Suppl 1():329-32. PubMed ID: 10093301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enigmatic relationship between Chlamydia pneumoniae and atherosclerosis.
    Zhang L; Ishikawa Y; Akasaka Y; Ito K; Ishii T
    Pathol Int; 2003 Oct; 53(10):733-4; author reply 734. PubMed ID: 14516327
    [No Abstract]   [Full Text] [Related]  

  • 37. Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma.
    Cook PJ
    J Antimicrob Chemother; 1999 Aug; 44(2):145-8. PubMed ID: 10473220
    [No Abstract]   [Full Text] [Related]  

  • 38. Mouse models of Chlamydia pneumoniae infection and atherosclerosis.
    Campbell LA; Kuo Cc
    Am Heart J; 1999 Nov; 138(5 Pt 2):S516-8. PubMed ID: 10539863
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chlamydia pneumoniae and atherosclerosis--the hen, the egg or five feathers?].
    Møller K; Skinhøj P
    Ugeskr Laeger; 1999 Sep; 161(37):5173-4. PubMed ID: 10523951
    [No Abstract]   [Full Text] [Related]  

  • 40. Animal models of chlamydia and atherosclerosis.
    Muhlestein JB
    Am Heart J; 1999 Nov; 138(5 Pt 2):S514-5. PubMed ID: 10539862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.